ClearPoint Neuro (CLPT) Change in Acquisitions & Divestments (2022)

ClearPoint Neuro's (CLPT) quarterly Change in Acquisitions & Divestments came in at $12.0 million in Q4 2022.

ClearPoint Neuro (CLPT) Change in Acquisitions & Divestments (2022) Analysis & Trends

ClearPoint Neuro has disclosed Change in Acquisitions & Divestments across 1 years of filings, most recently posting $12.0 million for Q4 2022.

  • Change in Acquisitions & Divestments for Q4 2022 came in at $12.0 million, changed N/A year-over-year; the trailing twelve-month figure through Sep 2024 was $12.0 million (changed N/A YoY), and the FY2023 annual result was $10.0 million, down 16.67% from the prior year.
  • Change in Acquisitions & Divestments came in at $12.0 million for Q4 2022 at ClearPoint Neuro.
  • In the past five years, Change in Acquisitions & Divestments ranged from a high of $12.0 million in Q4 2022 to a low of $12.0 million in Q4 2022.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 154.42 Bn 147.76 Bn 6.27 Bn
2 Stryker 118.12 Bn 115.25 Bn 3.81 Bn
3 Medtronic 101.72 Bn 93.55 Bn 5.76 Bn
4 Boston Scientific 67.19 Bn 65.98 Bn 3.61 Bn
5 Edwards Lifesciences 50.69 Bn 47.02 Bn 1.29 Bn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn
7 Dexcom 28.09 Bn 26.97 Bn 750.30 Mn
8 GE HealthCare Technologies 28.08 Bn 26.02 Bn 1.98 Bn
9 Steris 19.80 Bn 19.37 Bn 697.10 Mn
10 ClearPoint Neuro 524.46 Mn 488.86 Mn 7.76 Mn

Historic Data

Download Data
DateValue
Dec 31, 2022 12.00 Mn
Dec 31, 2022 12.00 Mn